Nimy John

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15

Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re‐Evaluating Age Limits in Transplantation Consortium

Allison J. Kwong, Deepika Devuni, Connie Wang et al. · Liver Transplantation · 2020 · 28 citations · Full text

Medicine, Geriatric Medicine, Surgery +15

Impact of Race and Socioeconomics Disparities on Survival in Young-Onset Colorectal Adenocarcinoma—A SEER Registry Analysis

Mark M. Aloysius, Hemant Goyal, Niraj James Shah et al. · Cancers · 2021 · 20 citations · Full text

Medicine, Biostatistics, Oncology +17

Sofosbuvir and Ledipasvir Versus Sofosbuvir and Simeprevir Combination Therapy in the Management of Acute Hepatitis C: A Randomized Open Label Prospective Clinical Pilot Study. SLAM C Study, Interim Data

Patrick Basu, Niraj James Shah, Nimy John et al. · The American Journal of Gastroenterology · 2015 · 12 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17